Raghuram Tangirala

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxosmithkline LLC, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghuram Tangirala. Retrieved from https://idiyas.com/inventor/raghuram-tangirala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 9.1

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 23(Granted Patents)

Location History:

Navi-Mumbai, IN (2014 - 2017)
Secunderabad, IN (2015 - 2019)

Company Filing History:

Glaxosmithkline Intellectual Property (No.2) Limited

patents

Years Active: 2014-2019

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10385066 - Compounds as diacylglycerol acyltransferase inhibitors (2019-08-20),

2. 10174049 - Compounds as diacylglycerol acyltransferase inhibitors (2019-01-08),

3. 9879031 - Compounds as diacylglycerol acyltransferase inhibitors (2018-01-30),

4. 9796729 - Compounds as diacylglycerol acyltransferase inhibitors (2017-10-24),

5. 9738658 - Compounds as diacylglycerol acyltransferase inhibitors (2017-08-22),

6. 9624174 - Compounds as diacylglycerol acyltransferase inhibitors (2017-04-18),

7. 9540400 - Compounds as diacylglycerol acyltransferase inhibitors (2017-01-10),

8. 9273069 - Compounds as diacylglycerol acyltransferase inhibitors (2016-03-01),

9. 9221766 - Compounds as diacylglycerol acyltransferase inhibitors (2015-12-29),

10. 9040517 - Compounds as diacylglycerol acyltransferase inhibitors (2015-05-26),

11. 8859536 - Compounds as diacylglycerol acyltransferase inhibitors (2014-10-14),

Title: Inventor Raghuram Tangirala: Innovations in Diacylglycerol Acyltransferase Inhibitors

Introduction

Raghuram Tangirala, a talented inventor based in Secunderabad, India, has made significant contributions to the field of biochemistry and pharmaceutical research. With a total of 11 patents to his name, his work focuses primarily on the development of compounds with specific biochemical applications. His innovative inventions have garnered attention and recognition in the industry.

Latest Patents

Among his latest patents is a groundbreaking invention concerning compounds as diacylglycerol acyltransferase inhibitors. This invention involves methods for the preparation of compounds that serve as inhibitors of acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT-1). The potential applications of these inhibitors are vital for research in metabolic disorders and therapeutic development.

Career Highlights

Throughout his career, Raghuram has worked with prominent companies such as GlaxoSmithKline LLC and GlaxoSmithKline Intellectual Property Limited. His career has been marked by a dedication to advancing pharmaceutical research and a passion for innovation.

Collaborations

Raghuram has had the opportunity to collaborate with esteemed colleagues such as Mui Cheung and Donghui Qin. These collaborations have undoubtedly contributed to the success of his inventions and the advancement of his research endeavors.

Conclusion

Raghuram Tangirala's innovative work in developing diacylglycerol acyltransferase inhibitors showcases his expertise and commitment to the field of biochemistry. With a growing portfolio of patents and a collaborative spirit, he is poised to continue making impactful contributions to pharmaceutical research and innovation.

Profile summary based on public USPTO records.